Skip to main content
. 2012 Aug 4;70(3):461–469. doi: 10.1007/s00280-012-1939-2

Fig. 2.

Fig. 2

Representative HPLC-RAD chromatographs for analyses of plasma, urine and feces samples. a Plasma sample collected 5 min prior to the end of the [14C]-barasertib infusion; b Urine sample collected 0–24 h from start of the [14C]-barasertib infusion; c Pooled feces sample collected 144–192 h from start of the [14C]-barasertib infusion. CPM counts per minute